Unternehmen Teva Pharmaceutical Industries Limited Other OTC
Aktien
906517
IL0006290147
TEVJF
Pharmazeutika
Kurzporträt
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Generics, Innovative Medicines and Over-the-counter Products
100,0
%
| 14 925 | 100,0 % | 15 846 | 100,0 % | +6.17% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
North America
51,3
%
| 7 452 | 49,9 % | 8 124 | 51,3 % | +9.02% |
Europe
30,5
%
| 4 525 | 30,3 % | 4 837 | 30,5 % | +6.90% |
International
12,4
%
| 1 903 | 12,8 % | 1 958 | 12,4 % | +2.89% |
Global
5,8
%
| 1 045 | 7,0 % | 926 | 5,8 % | -11.39% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01.01.23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22.12.19 |
Kathleen Veit
CMP | Compliance Officer | - | 01.01.10 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01.08.22 |
Amir Elstein
BRD | Director/Board Member | 67 | 01.01.95 |
Yael Ashman
IRO | Public Communications Contact | - | 01.09.09 |
Ran Meir
IRC | Investor Relations Contact | - | - |
Vikki Conway
HRO | Human Resources Officer | - | 01.01.10 |
Amir Weiss
AUD | Comptroller/Controller/Auditor | 47 | 01.06.12 |
Dov Bergwerk
SEC | Corporate Secretary | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01.09.15 |
Janet Vergis
BRD | Director/Board Member | 59 | 09.06.20 |
Sol Barer
CHM | Chairman | 76 | 01.01.15 |
Roberto Mignone
BRD | Director/Board Member | 52 | 14.07.17 |
Amir Elstein
BRD | Director/Board Member | 67 | 01.01.95 |
Rosemary Crane
BRD | Director/Board Member | 64 | 01.09.15 |
Richard Francis
CEO | Chief Executive Officer | 55 | 01.01.23 |
Perry Nisen
BRD | Director/Board Member | 68 | 14.07.17 |
Tal Zaks
BRD | Director/Board Member | 58 | 01.10.21 |
Director/Board Member | 52 | 01.06.18 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 1 238 592 397 | 1 126 136 620 ( 90,92 %) | 106 000 000 ( 8,558 %) | 90,92 % |
Unternehmenskontakt
Teva Pharmaceutical Industries Ltd.
124 Dvora HaNevi'a Street
6944020, Tel Aviv
+972 3 914 8213
http://www.tevapharm.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Teva Pharmaceutical Finance Co. BV
|
Finance/Rental/Leasing
|
Teva Pharmaceutical Finance Netherlands III BV
|
Finance/Rental/Leasing
|
Teva Pharmaceutical Finance Netherlands II BV
|
Finance/Rental/Leasing
|
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. |
Pharmaceuticals: Major
|
Teva Pharmaceutical Finance IV BV
|
Finance/Rental/Leasing
|
Teva Finance Services BV
Teva Finance Services BV Finance/Rental/LeasingFinance Part of Teva Pharmaceutical Industries Ltd., Teva Finance Services BV is a Dutch company that provides finance services. The company is located in the Netherlands. |
Finance/Rental/Leasing
|
Teva Finance Services II BV
Teva Finance Services II BV Finance/Rental/LeasingFinance Part of Teva Pharmaceutical Industries Ltd., Teva Finance Services II BV is a Dutch company that provides finance services. The company is located in the Netherlands. |
Finance/Rental/Leasing
|
Actavis Holding Asia BV
Actavis Holding Asia BV MiscellaneousMiscellaneous Part of AbbVie, Inc., Actavis Holding Asia holding company. The company is based in Haarlem, the Netherlands. |
Miscellaneous
|
Watson Pharma Pvt Ltd.
Watson Pharma Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Watson Pharma Pvt Ltd. is a pharmaceutical company founded in 2005. The company is based in Mumbai, India. The Indian company manufactures and supplies pharmaceutical products. |
Pharmaceuticals: Major
|
Sektor
Umsatz je Region
% 1. Jan. | Kap. | |
---|---|---|
+51.82% | 791 Mrd. | |
+40.45% | 630 Mrd. | |
+16.95% | 328 Mrd. | |
+9.49% | 298 Mrd. | |
+17.25% | 246 Mrd. | |
+0.41% | 225 Mrd. | |
+10.22% | 218 Mrd. | |
+5.30% | 160 Mrd. | |
-6.29% | 156 Mrd. |